Key result
Angiotensin II (10-100 nM) decreased the responsiveness of the isolated rat heart to beta1-adrenergic stimulation via activation of protein kinase C.
Angiotensin II decreases beta1-adrenergic responsiveness in the rat heart via activation of protein kinase C.
Should not alter beta-blocker use in patients; leaves open PKC as modulator of adrenergic signaling in heart failure models.
Cardiac beta-adrenergic receptors are the primary driving force for the enhancement of contractility in response to sympathetic stimulation. Angiotensin II influences cardiac function by modulating sympathetic activity and by activating cardiac angiotensin II receptors. The aim of this study was to determine whether activation of cardiac angiotensin II receptors modulates the responsiveness of the heart to beta-adrenergic receptor activation. Male Sprague-Dawley rats were anesthetized and the hearts isolated and perfused with oxygenated Krebs-Henseleit buffer (KHB). Coronary artery perfusion pressure, left ventricular pressure (LVP), left ventricular dP/dtmax, and heart rate (HR) were measured. Bolus administration of the beta-adrenergic receptor agonists, isoproterenol, dobutamine, and salbutamol, produced dose-related increases in LVP, LV dP/dt(max), and HR. Addition of angiotensin-II (10-100 nM) to the KHB slightly increased coronary perfusion pressure but did not alter baseline LVP, LV dP/dt(max), or HR. Angiotensin II reduced the increase in LVP, LV dP/dt(max), and HR elicited by isoproterenol and dobutamine but did not affect responses to salbutamol. The inhibitory effect of angiotensin II was blocked by the AT1-receptor antagonist, losartan, and the protein kinase C inhibitor, calphostin C (50 nM). Activation of protein kinase C with phorbol-12, 13-dibutyrate (PDBu; 10 nM) reduced cardiac responses to all three agonists, although the effects were less on responses elicited by salbutamol. These data suggest that activation of protein kinase C by angiotensin II decreases the responsiveness of the rat heart to beta 1-adrenergic stimulation and that angiotensin II-mediated protein kinase C activation may differ from that activated by phorbol esters.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (1997) studied Normal cardiac function (animal model). Angiotensin II vs. Baseline (absence of Angiotensin II) was evaluated on Responsiveness of left ventricular pressure, LV dP/dtmax, and heart rate to beta-adrenergic receptor activation. Angiotensin II (10-100 nM) decreased the responsiveness of the isolated rat heart to beta1-adrenergic stimulation via activation of protein kinase C.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: